Functional interaction of protein kinase CK2 and c-Myc in lymphomagenesis
- 2 August 2002
- journal article
- Published by Springer Nature in Oncogene
- Vol. 21 (34) , 5280-5288
- https://doi.org/10.1038/sj.onc.1205640
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 49 references indexed in Scilit:
- Protein kinase CK2 in mammary gland tumorigenesisOncogene, 2001
- Endogenous Protein Kinase CK2 Participates in Wnt Signaling in Mammary Epithelial CellsJournal of Biological Chemistry, 2000
- Emodin, an Anthraquinone Derivative Isolated from the Rhizomes of Rheum palmatum, Selectively Inhibits the Activity of Casein Kinase II as a Competitive InhibitorPlanta Medica, 1999
- Myc activates telomeraseGenes & Development, 1998
- p53 deficiency and misexpression of protein kinase CK2α collaborate in the development of thymic lymphomas in miceOncogene, 1998
- Inhibition of Cell Growth in Culture by QuinonesCancer Biotherapy & Radiopharmaceuticals, 1998
- In vivo degradation of N-myc in neuroblastoma cells is mediated by the 26S proteasomeOncogene, 1998
- Elevated protein kinase CK2 activity in chromatin of head and neck tumors: association with malignant transformationCancer Letters, 1996
- Casein kinase II is elevated in solid human tumours and rapidly proliferating non‐neoplastic tissueEuropean Journal of Biochemistry, 1990
- Cell-type specificity of iminunoglobulin gene expression is regulated by at least three DNA sequence elementsCell, 1985